ELICIO THERAPEUTICS
Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer. It offers potent vaccines and immunotherapies that enable precise targeting and delivery of immunogens directly to the lymphatic system, substantially enhancing the body's own system of immune defenses. The company was founded in 2011 and is based in Cambridge, Massachusetts.
ELICIO THERAPEUTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2011-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.elicio.com
Total Employee:
11+
Status:
Active
Contact:
(617)945-2077
Email Addresses:
[email protected]
Total Funding:
163.91 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Sitelinks Search Box Microsoft Exchange Online Office 365 Mail
Similar Organizations
ReCor Medical
ReCor Medical has developed a unique therapeutic non-focused ultrasound system
Recludix Pharma
Recludix pharma is a developing platform to treat cancer patients.
Nimbus Therapeutics
Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company.
Neukio Biotherapeutics
Neukio Biotherapeutics is a developer of allogenic immune cell therapies for treatment of cancer.
Vico Therapeutics
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
VYNE Therapeutics
VYNE Therapeutics developing proprietary, innovative and differentiated therapies in dermatology and beyond.
MindSciences
MindSciences develops and implements evidence-based mindfulness solutions that delight its customers.
Mersana Therapeutics
Mersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.
Actinium Pharmaceuticals
Actinium Pharmaceuticals develops alpha particle linked antibodies to treat cancer.
Avivomed
Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.
Alchemab Therapeutics
Alchemab Therapeutics is developing natural protective antibodies designed to keep people free of hard-to-treat diseases.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Aratana Therapeutics
Aratana Therapeutics develops innovative therapies for the animal health industry.
Abcuro
Abcuro develops first-in-class immunotherapies to treat autoimmunity and cancer.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
AccenGen Therapeutics
Early stage therapeutics developing novel first-in-class anti-inflammatory medications
Endpoint Health
Precision Immunology Therapies
Elstar Therapeutics
Fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapeutics.
EverImmune
EverImmune provides therapeutic tools related to cancer.
7 Hills Pharma
7 Hills Pharma is developing novel immunotherapies for the treatment Of cancer.
TCR2
TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Tallac Therapeutics
Tallac Therapeutics offers next generation immunotherapies for cancer patients.
Tempo Therapeutics
Tempo Therapeutics develops materials that are immune stealth, minimally invasive, and precision-engineered for regenerative medicine.
Unleash Immuno Oncolytics
Unleashing the immune response to treat cancer.
Serenity Bioworks
Developing therapeutics derived from cellular stress pathways.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Spinal Cord Therapeutics GmbH
Spinal Cord Therapeutics GmbH develops treatments for spinal cord injury.
Dynomics
Molecules to restore heart function.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Domain Therapeutics
Domain Therapeutics develops small molecules targeting G-coupled protein receptors.
HbO2 Therapeutics
HbO2 Therapeutics develops and manufactures oxygen carrying solutions.
Iaso Therapeutics
Iaso Therapeutics develops vaccines to improve human health and cure diseases.
IDM Pharma
IDM develops immunotherapies for cancer
IMTherapeutics
IM Therapeutics develops personalized immuno-therapeutic drugs.
Inceptor Bio
Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers.
GITR
GITR develops therapies to enhance the immune system by enabling T cells to be more effective in attacking cancer cells.
GO Therapeutics
A new generation of cancer immunotherapy promise to change the paradigm of cancer treatment.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Glyscend
Glyscend develops a revolutionary approach to treating type 2 diabetes.
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Osmol Therapeutics
Osmol Therapeutics develops treatment to prevent chemotherapy-induced peripheral neuropathy.
Oncorus
Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.
Oxford Vacmedix
Develop therapeutic agents for the treatment of cancer .
OncoPep
OncoPep is a developer of a multi-peptide therapeutic vaccine to prevent the progression of cancer.
Zylö Therapeutics
Zylö Therapeutics offers an innovative sustained-release drug-delivery system.
Carrick Therapeutics
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
Clade Therapeutics
Clade Therapeutics discovers and delivers next-generation cell medicines to improve the lives of patients.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
CODA Biotherapeutics
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.
Click Therapeutics
Click Therapeutics delivers safe and effective digital treatments to patients in need.
PanTher Therapeutics
PanTher Therapeutics features treatment platform designed to enhance therapeutic response with minimal side effects.
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
Current Advisors List
Current Employees Featured
Founder
Investors List
Trend Investment Group
Trend Investment Group investment in Series B - Elicio Therapeutics
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group investment in Series B - Elicio Therapeutics
Clal Biotechnology Industries
Clal Biotechnology Industries investment in Series B - Elicio Therapeutics
EFung Capital
EFung Capital investment in Series B - Elicio Therapeutics
Thynk Capital, LLC.
Thynk Capital, LLC. investment in Venture Round - Elicio Therapeutics
Access BridgeGap Ventures
Access BridgeGap Ventures investment in Venture Round - Elicio Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-12 | Elicio Therapeutics Announces Appointment of Joy Seymour as Vice President, Head of Regulatory Affairs and Promotion of Dr. Peter DeMuth to Chief Scientific Officer |
Official Site Inspections
http://www.elicio.com Semrush global rank: 5.53 M Semrush visits lastest month: 1.54 K
- Host name: elicio.tempurl.host
- IP address: 45.76.164.42
- Location: Matawan United States
- Latitude: 40.4652
- Longitude: -74.2307
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07747
